Dermal fillers and biostimulatory agents are not interchangeable even for the most experienced practitioner of injectables. The term “filler” can sometimes be used by patients to refer to volume, and on other occasions it is used to refer to a complete facial rejuvenation, to return to the pre-aging face of the patient. Two very different problems that require two completely different solutions.
The article below will outline the key differences between biostimulatory injectables and conventional hyaluronic acid (HA) fillers. This comparison will aim to guide the practitioner on how to select between the two classes of products for injection, as well as manage the patient’s realistic expectations on the achievable outcome.
Two different jobs in the tissue
Hyaluronic acid is a space-occupying product, a hydrophilic, reversible product, which immediately creates a change that can be shaped during the treatment. The product can be dissolved if the created result starts to drift.
So, a biostimulator does not occupy space in the long term. As a foreign body, it will induce a foreign body response, which will result in a lot of new collagen fibers being produced by the fibroblasts in the tissue. This process takes weeks, and so the immediate post-injection fullness caused by the diluent used to dissolve the product in the syringe will go down in a matter of days.
Why the distinction changes the injection plan
For space-occupying products, such as fillers, technique is best applied to very defined areas of the face. Pyriform aperture, deep medial cheek etc. For collagen-stimulating products, distribute evenly over a broad plane of tissue in an attempt to ‘seed’ a tissue response. Lifting agents are best treated as such, in defined boluses of filler. Treating collagen-stimulators as space-occupying fillers can result in many unwanted nodules of collagen instead.
How results develop over time
Note, The timeline for the effects of these different products is quite different and must be outlined to the patient prior to giving consent for the treatment.
- Hyaluronic acid, correction visible immediately, settling over two weeks as swelling resolves and the gel integrates.
- Calcium hydroxylapatite, partial immediate volume from the carrier gel, collagen contribution building from roughly the second month.
- Poly-L-lactic acid, essentially no lasting immediate change, with visible improvement typically emerging between six and twelve weeks and continuing across a treatment series.
Those patients who have an understanding of the need for multiple treatments to reach their aesthetic goal, and complete the required number of treatments within the allotted time frame, report very positive results. Those patients who believe that they can get immediate lasting results from one treatment (i.e. A “mirror moment” in the treatment room), will typically be very disappointed with their results after the first treatment.
Comparing the categories on the criteria that drive selection
| Criterion | Hyaluronic acid filler | Collagen-stimulating injectable |
| Onset of visible result | Same day | Six to twelve weeks |
| Typical duration | Six to eighteen months by product and site | Two years or more after a completed series |
| Sessions to full effect | Usually one | Commonly two to four, spaced four to six weeks |
| Reversibility | Hyaluronidase | None, management is conservative |
| Best suited to | Defined contour, lip, tear trough, sharp structural change | Diffuse volume loss, skin quality, temples, midface, jawline support |
| Main failure mode | Overfill, migration, distortion with repeated top-ups | Nodules from poor dilution, uneven distribution, or shallow placement |
Matching the product to the treatment goal
Here are two different goals, and thus two different ways of approaching these goals. First, define the patient’s goals. Are they trying to attain a specific goal, for example a more defined jaw angle for a child’s wedding in 3 weeks? If so, then fillers are the best approach. On the other hand, a late 40s/early 50s patient with generalized deflation of the midface, and thinning of the temples, with no specific timeline, would probably benefit from a biostimulator approach. These types of treatments are typically approached in a staged manner over the course of several months, and for a patient in this position a course of Sculptra Jacksonville treatments is well worth considering.
A practical decision sequence
- Establish whether the complaint is loss of structure, loss of skin quality, or both.
- Confirm the patient’s timeline and tolerance for a delayed result.
- Assess skin thickness and existing filler burden, since heavily filled midfaces often need dissolution before anything else is useful.
- Decide whether reversibility is clinically necessary, particularly in high-risk vascular territory.
- Sequence the plan, using biostimulation as the foundation and hyaluronic acid for definition afterward.
Combining rather than choosing
It is best to layer collagen-stimulating biostimulators for the best results. The initial treatment should allow time to mature and then a determination can be made for additional treatments, possibly using fillers to enhance the overall outcome.
Documenting the difference
We need photographs of the patient before the first treatment, and then at each subsequent treatment. At 3 months post treatment we need a final set of photographs. The patient will probably remember little change between photographs for the same treatment session. However, the practitioner will have a permanent record of the patient’s progress and can show the patient’s improvements over time. The photographs must be taken with consistent lighting and head position for accurate and reliable assessment of change.
